Onderneming Deciphera Pharmaceuticals, Inc.
Aandelen
DCPH
US24344T1016
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
25,35 USD | +0,32% | +72,26% | +56,66% |
30/04 | DECIPHERA PHARMACEUTICALS, INC. : Leerink Partners haalt aandeel van kooplijst | ZM |
30/04 | DECIPHERA PHARMACEUTICALS, INC. : JMP Securities past advies naar Neutraal aan | ZM |
Vakgebied
Aantal werknemers: 355
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Switch Control Kinase Inhibitor Platform
100,0
%
| 126 | 100,0 % | 159 | 100,0 % | +26,75% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
76,4
%
| 97 | 77,5 % | 122 | 76,4 % | +25,03% |
Rest of World
12,3
%
| 14 | 11,1 % | 20 | 12,3 % | +39,91% |
Germany
11,3
%
| 14 | 11,4 % | 18 | 11,3 % | +25,58% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Hoerter
CEO | Chief Executive Officer | 53 | 17-05-18 |
Tucker Kelly
DFI | Director of Finance/CFO | 53 | 01-02-15 |
Kevin Brodbeck
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-23 |
Chief Tech/Sci/R&D Officer | - | 01-01-17 | |
Dashyant Dhanak
CTO | Chief Tech/Sci/R&D Officer | 63 | 05-09-23 |
Matthew Sherman
CTO | Chief Tech/Sci/R&D Officer | 68 | 02-10-19 |
Lisa Amaya Price
HRO | Human Resources Officer | - | 01-01-22 |
Kelley Dealhoy
PRN | Corporate Officer/Principal | - | 16-06-22 |
Jama Pitman
PRN | Corporate Officer/Principal | 45 | 01-01-15 |
Daniel Martin
PRN | Corporate Officer/Principal | 49 | 18-09-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Patricia Allen
BRD | Director/Board Member | 62 | 01-09-16 |
Edward Benz
BRD | Director/Board Member | 78 | 01-07-19 |
Ron Squarer
CHM | Chairman | 57 | 04-12-19 |
John R. Martin
BRD | Director/Board Member | 63 | 01-02-15 |
James Bristol
BRD | Director/Board Member | 77 | 01-08-07 |
Susan Kelley
BRD | Director/Board Member | 69 | 08-07-19 |
Steven Hoerter
CEO | Chief Executive Officer | 53 | 17-05-18 |
Dennis Walsh
BRD | Director/Board Member | 56 | 01-02-15 |
Director/Board Member | 66 | 01-11-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 82 225 972 | 57 541 331 ( 69,98 %) | 0 | 69,98 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+56,66% | 2,08 mld. | |
-3,46% | 102 mld. | |
+1,41% | 96,09 mld. | |
+2,13% | 22,28 mld. | |
-15,84% | 21,4 mld. | |
-9,28% | 18,14 mld. | |
-39,98% | 17,02 mld. | |
-14,65% | 16,09 mld. | |
+4,39% | 13,83 mld. | |
+31,35% | 11,97 mld. |
- Beurs
- Aandelen
- Koers DCPH
- Onderneming Deciphera Pharmaceuticals, Inc.